Please login to the form below

Not currently logged in
Email:
Password:

HIV

This page shows the latest HIV news and features for those working in and with pharma, biotech and healthcare.

Gilead delivers a “solid quarter” with revenues up $1.52bn

Gilead delivers a “solid quarter” with revenues up $1.52bn

Gilead attributes the revenue rise to its COVID-19 drug, HIV therapy and hepatitis C virus products. ... Recent results in virology for lenacapavir, which reinforces its potential as a long-acting therapy for people living with HIV.

Latest news

More from news
Approximately 92 fully matching, plus 550 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 4 fully matching, plus 53 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 17 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 4 fully matching, plus 33 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Branding Science

We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...

Latest intelligence

Guide
How to embrace behavioural science principles in healthcare MR...
Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand
The Impetus InSite Platform® can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. Here, we share 10 of the most popular ways to...
Employee wellbeing in creative agencies: three tips to get you started
Paul Hutchings, founder of fox&cat, and new friend, Welfy, a workplace wellbeing training firm, discuss the importance of collaboration...